Learn about the financial strain caused by the skyrocketing demand and costs of GLP-1 drugs, and how health plans and providers are struggling to balance it.
These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...
American Heart Association and American Stroke Association have released new Stroke prevention guidelines, with focus on pregnant women and those consuming GLP-1 drugs. Each year, over 140,000 ...
The uptake of GLP-1 has surged since 2022, mainly in US. Read our takeaways from the UBS Evidence Lab survey on key trends in GLP-1 consumer behaviour GLP-1s, also known as glucagon-like peptide 1, ...
As more people turn to GLP-1 agonists (such as semaglutide) for weight loss, nutrient deficiencies appear to be rising. Although hard data doesn’t yet exist on how many people taking Ozempic ...
At the J.P. Morgan Health Care conference this week in San Francisco, drugmakers had their sights set on the next generation of GLP-1 medications, alternatives, and a growing list of indications ...
A new study reports that GLP-1 medications may provide benefits to cognitive and behavioral health, including lowered addiction risk. Scientists also confirmed that the use of these medications ...